IRIS
PINTON, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 757
NA - Nord America 563
AS - Asia 162
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 555
IE - Irlanda 216
IT - Italia 153
SE - Svezia 119
DE - Germania 105
UA - Ucraina 64
SG - Singapore 45
FI - Finlandia 36
IN - India 36
CN - Cina 33
HK - Hong Kong 24
GB - Regno Unito 23
FR - Francia 20
TR - Turchia 9
CA - Canada 8
IR - Iran 7
CZ - Repubblica Ceca 6
VN - Vietnam 6
BE - Belgio 5
CH - Svizzera 3
RU - Federazione Russa 3
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
LT - Lituania 1
NL - Olanda 1
PK - Pakistan 1
RO - Romania 1
Totale 1.483
Salva come PNG Salva come JPEG
Città #
Dublin 214
Jacksonville 122
Dearborn 57
Piemonte 37
Ann Arbor 33
Wilmington 33
Singapore 30
Chandler 28
Hong Kong 24
Lawrence 23
Princeton 23
Bremen 20
Beijing 19
Strasbourg 17
Milan 14
Andover 12
Ashburn 11
San Mateo 11
Turin 10
Kocaeli 9
Norwalk 8
Bari 6
Brno 6
Dong Ket 6
Novara 6
Boardman 5
Brussels 5
Bologna 4
Helsinki 4
Houston 4
Kunming 4
Monmouth Junction 4
Mülheim 4
Nanjing 4
Vercelli 4
Woodbridge 4
Arcene 3
Leawood 3
Portland 3
Rome 3
Sacramento 3
Toronto 3
Winnipeg 3
Zanjan 3
Des Moines 2
Fairfield 2
Falkenstein 2
Fuzhou 2
Grafing 2
Henderson 2
Munich 2
Ottawa 2
Santa Clara 2
Zurich 2
Amsterdam 1
Ardabil 1
Athens 1
Bangalore 1
Berlin 1
Biella 1
Bresso 1
Cambridge 1
Cento 1
Chongqing 1
Erding 1
Frankfurt am Main 1
Hefei 1
Horia 1
Islamabad 1
Jinan 1
Lanzhou 1
Lausanne 1
Nepi 1
Perm 1
Seattle 1
Torino 1
Vigonza 1
Yaraichō 1
Totale 893
Salva come PNG Salva come JPEG
Nome #
Pharmaceutical combinations comprising estrogen receptor-beta agonists with platinum drugs or paclitaxel for treating ovarian cancer 89
SIRT1 at the crossroads of AKT1 and ERβ in malignant pleural mesothelioma cells. 84
PARP1 inhibition affects Pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1 82
Tissue transglutaminase (TG2) enables survival of human malignant pleural mesothelioma cells in hypoxia 68
Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality 66
Intracellular lactate-mediated induction of estrogen receptor beta (ERβ) in biphasic malignant pleural mesothelioma cells 63
8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3OH kinase activity 60
Expression and therapeutic significance of estrogen receptor beta (ERβ) in malignant pleural mesothelioma 57
Inhibition of the histone methyltransferase ezh2 enhances protumor monocyte recruitment in human mesothelioma spheroids 57
Estrogen receptor beta agonists for use in treating mesothelioma 55
KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma 55
Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesothelioma 54
Coordinated sumoylation and ubiquitination modulate EGF induced EGR1 expression and stability 53
Circulating tumor cells as a diagnostic test for malignant pleural mesothelioma 53
Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity 51
Estrogen receptor beta impacts on prognosis of human malignant mesothelioma 50
Flavonoid-induced autophagy in hormone-sensitive breast cancer cells 50
Therapies currently in phase II trials for malignant mesothelioma 50
ESTROGEN RECEPTOR ß ACTIVATION IMPAIRS MITOCHONDRIAL OXIDATIVE METABOLISM AND AFFECTS MALIGNANT MESOTHELIOMA CELL GROWTH IN VITRO AND IN VIVO 49
Estrogen receptor beta exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib 48
Specific low-frequency electromagnetic fields induce expression of active KDM6B associated with functional changes in U937 cells 47
Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review 47
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment 46
Transglutaminase 2 maintains a colorectal cancer stem phenotype by regulating epithelial-mesenchymal transition 45
CDKN2A determines mesothelioma cell fate to EZH2 inhibition 42
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 35
A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment 32
Benefits and Challenges of Inhibiting EZH2 in Malignant Pleural Mesothelioma 15
The Strange Case: The Unsymmetric Cisplatin-Based Pt(IV) Prodrug [Pt(CH3COO)Cl2(NH3)2(OH)] Exhibits Higher Cytotoxic Activity with respect to Its Symmetric Congeners due to Carrier-Mediated Cellular Uptake 13
Epigenetic Insights on PARP-1 Activity in Cancer Therapy 12
Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1 10
Totale 1.538
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020244 0 0 0 2 33 41 44 8 24 52 39 1
2020/2021186 24 5 22 1 19 3 23 1 27 26 27 8
2021/2022230 9 3 24 32 8 0 13 7 17 9 57 51
2022/2023464 25 17 27 10 27 44 5 29 224 8 28 20
2023/2024170 28 8 16 10 25 2 27 2 1 4 21 26
2024/202560 15 7 38 0 0 0 0 0 0 0 0 0
Totale 1.538